University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT02613390
The goal of this clinical research study is to learn about the safety and accuracy of using MRI as a guidance system during laser ablation surgery of tumors that have spread to the spine.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Study Visits:
If you agree to take part in this study, before your surgery:
During the Surgery:
You will be positioned lying face down on your stomach during surgery. While you are under anesthesia, an MRI will be used to take images of your spine. This is an intraoperative MRI, meaning that it is performed in a special magnet located inside a specifically designed operating room. These images will be loaded into a computer navigation program and will be used to help the doctor perform surgery.
Markers will also be attached to the skin of your back. These markers are used together with the navigation program and MRI images to record the location of where on your spine the doctor should cut. This recording will be compared to the MRI images.
Your doctor will check the accuracy of this recording in 2 ways:
If there is a difference in the result of these 2 measurements, your doctor will use the result of the first step to check the accuracy of the MRI image.
If there is more than 2 millimeter difference between the visual inspection position and the computer model position, your doctor may decide to do one of the following steps:
On the Day After Surgery:
Follow-Up Visits:
The research staff will call you 3 weeks after surgery to ask about your recovery and you will be asked to answer the same questionnaires as before.
You will return for a follow-up visit after surgery:
Length of Study Participation:
Your participation in the study will be over after your follow-up visit.
You will be taken off study if during surgery the doctor thinks the navigation is not accurate, you are injured related to an inaccurate image guidance, or your surgery is stopped.
This is an investigational study. The MRIs and x-rays on this study are performed using FDA-approved and commercially available methods. The use of MRI as image guidance for spinal surgery is investigational.
Up to 10 participants will be enrolled in this study. All will take part at MD Anderson.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MRI images of the spine taken of anesthetized participant in the operative prone position.
Other names: MRI
Pain and symptom questionnaires completed at baseline and at follow up.
Other names: Surveys
Time frame: 3 weeks
Safety of Intraoperative MRI-Based Image Guidance to Perform Laser Ablation of Epidural Metastasis
Time frame: 1 day
Navigation considered inaccurate if there is a discrepancy of more than 2mm between the real position of the probe confirmed by direct visual inspection, and the computer model displayed on the navigation screen.
M.D. Anderson Cancer Center
Other
A Pilot Study to Evaluate Safety of Intraoperative MRI-Based Image Guidance for Laser Ablation of Epidural Metastasis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01624220
Adenocarcinoma, Breast Diseases
Houston, Texas, United States
View Trial DetailsNCT07354178
Back Injuries, Blood Loss, Surgical
Seoul, Gangnam-gu, South Korea
View Trial DetailsNCT03052738
Brain Diseases, Brain Neoplasms
Aurora, Colorado, United States
View Trial DetailsNCT02790294
Central Nervous System Diseases, Central Nervous System Neoplasms
Cleveland, Ohio, United States
View Trial Details